Brachytherapy, the Official Journal of the American Brachytherapy Society, Expands to Six Issues in 2011
New York, NY, April 12, 2011 – Elsevier, a world leader in health care and medical publishing and online solutions, today announced the significant expansion of scientific content to be published in Brachytherapy ( www.brachyjournal.com), the Official Journal of the American Brachytherapy Society (ABS).
Published both online and in print, this international, multidisciplinary journal moves from a quarterly to bimonthly publication schedule in 2011. In addition, a meeting abstracts supplement will be published annually. These changes reflect Elsevier’s and ABS’s ongoing commitment to their mission to provide radiation oncologists, other physicians, physicists, and others interested in brachytherapy with the timely information they need to advance the quality and access to state-of-the-science treatments for their patients.
“The ABS Journal is a great success story for the association. Moving to six issues per year is a positive indication of the growing recognition of the journal and we are confident this will assist the ABS with increasing its membership as well,” commented Rick Guggolz, Executive Director of the ABS. “Through the efforts of our Editorial Staff and Editorial Board, Brachytherapy is a beneficial, tangible and consistent resource for our members.”
Under the editorial leadership of Michael J. Zelefsky, MD, Chief of Brachytherapy Service, Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, and an internationally recognized editorial board, Brachytherapy presents original peer-reviewed articles and selected reviews on the techniques and clinical applications and medical physics related aspects of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include radiation oncology, radiology, medical physics and medical oncology.
Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited; Letters to the Editor-in-Chief are encouraged.
“We anticipate that Brachytherapy will continue to thrive and expand as a forum for global information exchange about vital topics in the field, to the benefit of our authors, patients, society members and wider readership,” stated Herb Niemirow, Publisher at Elsevier. “We will be able to better position the journal in an increasingly complex publishing environment and take advantage of emerging publishing opportunities.”
Later this year the Brachytherapy website will launch a new user interface designed to enable visitors to locate specific content or browse issues even more quickly and easily. Brachytherapy will be featured at the American Brachytherapy Society 2011 Annual Meeting in San Diego, CA, April 14-16, 2011.
# # #
Notes for Editors
About the American Brachytherapy Society
The American Brachytherapy Society ( www.americanbrachytherapy.org) was founded in 1978 to provide insight, rationale, and research into the use of brachytherapy in the treatment of both malignant and benign conditions. The organization consists of physicians, physicists, and others interested in brachytherapy.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Herb Niemirow, Publisher
Health Sciences Journals
Tel: +1 212-633-3141